NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Hereditary Spastic Paraplegia
    Hereditary Spastic Paraplegia
    medium
    stethoscope Medicine

    A 38-year-old man presents with a 5-year history of progressive stiffness and weakness in both lower limbs. On examination, he has a scissor gait, brisk reflexes, bilateral ankle clonus, and extensor plantar responses. MRI brain and spine are normal. Genetic testing reveals a mutation in the SPAST gene. The inheritance pattern marked **B** in the diagram (Autosomal dominant SPAST/SPG4) accounts for what proportion of autosomal dominant hereditary spastic paraplegia cases?

    A. 15-20%
    B. 60-70%
    C. 40-45%
    D. 25-30%

    Explanation

    Why 40-45% is right

    SPG4 (SPAST gene mutations) is the most common autosomal dominant form of hereditary spastic paraplegia, accounting for 40-45% of all AD-HSP cases. The SPAST gene encodes spastin, a microtubule-severing ATPase critical for axonal microtubule dynamics and maintenance of corticospinal tract integrity. This patient's clinical presentation (progressive lower limb spasticity, hyperreflexia, ankle clonus, bilateral Babinski signs, normal MRI, and SPAST mutation) is pathognomonic for SPG4/AD-HSP. Understanding the relative frequency of SPG4 among AD-HSP subtypes is essential for genetic counseling and anticipating disease course in Indian populations where HSP prevalence is 1-9 per 100,000.

    Why each distractor is wrong

    • 25-30%: This underestimates the true frequency of SPG4. While other AD forms (SPG3A, SPG31) exist, SPG4 remains the dominant subtype and accounts for nearly half of AD-HSP, not one-quarter.
    • 60-70%: This overestimates SPG4 frequency. Although AD-HSP comprises 70-80% of all HSP cases, SPG4 accounts for 40-45% of AD-HSP specifically, not 60-70%.
    • 15-20%: This significantly underestimates SPG4 prevalence. Such a low figure would place SPG4 among rare AD-HSP subtypes, contradicting its status as the most common form.
    High-YieldNEET PG
    SPG4 (SPAST mutations) = 40-45% of AD-HSP; AD-HSP = 70-80% of all HSP; therefore SPG4 ≈ 30-35% of total HSP burden.

    GeneReviews HSP 2024; Brain 2023

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions